TITLE:
Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria

CONDITION:
Gram-Positive Bacterial Infections

INTERVENTION:
daptomycin

SUMMARY:

      The purpose of this study is to provide daptomycin, an antibiotic, to patients who are
      failing conventional therapy, or who cannot take approved antibiotics for one reason or
      another.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 18 Years to N/A
Criteria:

        Main Inclusion Criteria:

          -  Infection caused by Staphylococcus aureus, Staphylococcus epidermidis, Enterococcus
             faecalis, or Enterococcus faecium that requires inpatient hospitalization and
             treatment with injectable antibiotics**

          -  Site of infection: complicated skin and skin structure infection; urinary tract
             infection; intra-abdominal infection; infective endocarditis; or bloodstream
             infection (including catheter-related).

          -  Pathogen resistant to, or patient intolerant of: beta-lactams, vancomycin,
             quinupristin/dalfopristin, or linezolid.

          -  Unable to receive any other standard commercially available antibacterial therapy for
             the infection.

        Main Exclusion Criteria:

          -  Creatinine clearance less than 40 mL/min**

          -  Hemodialysis or peritoneal dialysis

          -  Admitted to the hospital for drug overdose or other conditions associated with
             rhabdomyolysis, or is expected to require repeated intramuscular injections

          -  Creatine phosphokinase (CPK) level greater than 2.5 times above the upper limit of
             normal (ULN) at screening; if the elevation in CPK can be attributed to an obvious
             cause (eg, surgery)**

          -  Central nervous system infection

          -  Pulmonary infection.

        (**) An exemption may be granted for patients not satisfying these criteria following a
        conversation with the Medical Monitor.
      
